Clinical Trial Update: Effect of Triclosan-coated Suture on Superficial SSI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether triclosan-coated sutures reduce superficial surgical site infections; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• Vicryl Plus Antibacterial Suture (polyglactin 910 suture coated with triclosan)

Snippet

Sponsor: Hospital General Universitario Elche | Conditions: Surgical Site Infection | Phase 3 | Status: COMPLETED